Schedule 13G ownership disclosure
Bellerophon Therapeutics, Inc.
Security class unavailable · CUSIP: 078771102
Event date: 2016-11-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-065965
- Form type
- SC 13G
- Filer
- Bellerophon Therapeutics, Inc.
- CIK
- CIK 1600132
- Filed
- Mar 01, 2017
- Reporting period
- Nov 23, 2016
- Description
- Schedule 13G beneficial ownership